320 related articles for article (PubMed ID: 32157676)
1. Use of immunotherapy and surgery for stage IV melanoma.
Molina G; Kasumova GG; Qadan M; Boland GM
Cancer; 2020 Jun; 126(11):2614-2624. PubMed ID: 32157676
[TBL] [Abstract][Full Text] [Related]
2. Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
Bello DM; Panageas KS; Hollmann T; Shoushtari AN; Momtaz P; Chapman PB; Postow MA; Callahan MK; Wolchok JD; Brady MS; Coit DG; Ariyan CE
Ann Surg Oncol; 2020 Apr; 27(4):1180-1188. PubMed ID: 31848819
[TBL] [Abstract][Full Text] [Related]
3. Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint Inhibitors.
Jain V; Venigalla S; Reddy VK; Lukens JN; Mitchell TC; Shabason JE
J Immunother; 2020 Jan; 43(1):8-15. PubMed ID: 31498180
[TBL] [Abstract][Full Text] [Related]
4. Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy Era.
Lwin TM; Kaelberer Z; Ruan M; Molina G; Boland G
Ann Surg Oncol; 2023 Aug; 30(8):5005-5012. PubMed ID: 37121988
[TBL] [Abstract][Full Text] [Related]
5. The impact of effective systemic therapies on surgery for stage IV melanoma.
Smith MJF; Smith HG; Joshi K; Gore M; Strauss DC; Hayes AJ; Larkin J
Eur J Cancer; 2018 Nov; 103():24-31. PubMed ID: 30196107
[TBL] [Abstract][Full Text] [Related]
6. Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
Nelson DW; Fischer TD; Graff-Baker AN; Dehal A; Stern S; Bilchik AJ; Faries MB
Ann Surg Oncol; 2019 Dec; 26(13):4610-4618. PubMed ID: 31183639
[TBL] [Abstract][Full Text] [Related]
7. Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI)
Safi M; Al-Azab M; Jin C; Trapani D; Baldi S; Adlat S; Wang A; Ahmad B; Al-Madani H; Shan X; Liu J
Front Immunol; 2021; 12():609728. PubMed ID: 34887846
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant immunotherapy for melanoma.
Thomas D; Bello DM
J Surg Oncol; 2021 Mar; 123(3):789-797. PubMed ID: 33595889
[TBL] [Abstract][Full Text] [Related]
9. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
[TBL] [Abstract][Full Text] [Related]
10. Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
Chick RC; Faries MB; Hale DF; Kemp Bohan PM; Hickerson AT; Vreeland TJ; Myers JW; Cindass JL; Brown TA; Hyngstrom J; Berger AC; Jakub JW; Sussman JJ; Shaheen M; Clifton GT; Park H; Sloan AJ; Wagner T; Peoples GE
Cancer Med; 2021 Jul; 10(13):4302-4311. PubMed ID: 33982452
[TBL] [Abstract][Full Text] [Related]
11. Role of Surgery for Metastatic Melanoma.
Enomoto LM; Levine EA; Shen P; Votanopoulos KI
Surg Clin North Am; 2020 Feb; 100(1):127-139. PubMed ID: 31753107
[TBL] [Abstract][Full Text] [Related]
12. Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US.
Moyers JT; Patel A; Shih W; Nagaraj G
JAMA Netw Open; 2020 Sep; 3(9):e2015656. PubMed ID: 32876684
[TBL] [Abstract][Full Text] [Related]
13. Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies.
Ch'ng S; Uyulmaz S; Carlino MS; Pennington TE; Shannon KF; Rtshiladze M; Stretch JR; Nieweg OE; Varey AHR; Hsiao E; Kapoor R; Pires da Silva I; Lo SN; Spillane AJ; Scolyer RA; Long GV; Hong AM; Saw RPM; Thompson JF; Menzies AM
Eur J Cancer; 2021 Aug; 153():8-15. PubMed ID: 34126335
[TBL] [Abstract][Full Text] [Related]
14. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract][Full Text] [Related]
15. Metastasectomy for stage IV melanoma.
Deutsch GB; Kirchoff DD; Faries MB
Surg Oncol Clin N Am; 2015 Apr; 24(2):279-98. PubMed ID: 25769712
[TBL] [Abstract][Full Text] [Related]
16. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.
Li AT; Vakharia K; Lo SN; Varey AHR; Carlino MS; Saw RPM; Shannon KF; Howle JR; Pennington TE; Stretch JR; Nieweg OE; Spillane AJ; Long GV; Menzies AM; Scolyer RA; Thompson JF; Ch'ng S
Ann Surg Oncol; 2021 Oct; 28(11):6109-6123. PubMed ID: 34347220
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era?
Bello DM; Ariyan CE
Ann Surg Oncol; 2020 Apr; 27(4):1189-1190. PubMed ID: 31953700
[No Abstract] [Full Text] [Related]
18. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.
Ridolfi L; Ridolfi R; Riccobon A; De Paola F; Petrini M; Stefanelli M; Flamini E; Ravaioli A; Verdecchia GM; Trevisan G; Amadori D
J Immunother; 2003; 26(2):156-62. PubMed ID: 12616107
[TBL] [Abstract][Full Text] [Related]
19. Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB-IV M1c melanoma patients.
Fröhlich A; Niebel D; Fietz S; Egger E; Buchner A; Sirokay J; Landsberg J
Cancer Immunol Immunother; 2020 May; 69(5):759-769. PubMed ID: 32052079
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
Zaremba A; Philip M; Hassel JC; Glutsch V; Fiocco Z; Loquai C; Rafei-Shamsabadi D; Gutzmer R; Utikal J; Haferkamp S; Reinhardt L; Kähler KC; Weishaupt C; Moreira A; Thoms KM; Wilhelm T; Pföhler C; Roesch A; Ugurel S; Zimmer L; Stadtler N; Sucker A; Kiecker F; Heinzerling L; Meier F; Meiss F; Schlaak M; Schilling B; Horn S; Schadendorf D; Livingstone E
Eur J Cancer; 2021 Jul; 152():139-154. PubMed ID: 34102453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
